For the quarter ending 2025-06-30, SGMT had -$33,513K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-06-30 |
|---|---|
| Net (decrease) increase in cash and cash equivalents | -33,513 |
Sagimet Biosciences Inc. (SGMT)
Sagimet Biosciences Inc. (SGMT)